A9543 Y90 ibritumomab, rx

Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1 units per day (practitioner), rationale: Code Descriptor / CPT Instruction